When will Beam Therapeutics submit a BLA for Risto-cel?
Prediction market on kalshi. If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
Liquidity: $83.42. Resolves: 10/8/2026.